Decoding Receptor Signaling: How a Precise Hormone Trigger Helped Map the Hidden Life of LHR
G protein-coupled receptors (GPCRs) are some of the busiest and most important molecules in the body. They help cells respond to hormones, neurotransmitters, and environmental cues—and they do it all while constantly moving, interacting, and changing shape. One of the trickiest to study is the luteinizing hormone receptor (LHR), a GPCR critical to human reproduction.
A recent paper in Cell Chemical Biology brought new clarity to this complex receptor using a powerful approach called APEX2 proximity proteomics. At the heart of this innovation? A biologically active and consistent supply of luteinizing hormone, sourced from Golden West BioSolutions.
The Challenge: Following a Moving Target
Studying GPCRs like LHR is tough because they don’t stay put. Once activated by their ligand—in this case, LH—these receptors rapidly internalize into the cell and move through compartments like the very early endosome (VEE). VEE is a specialized cellular compartment involved in the initial sorting and trafficking of internalized receptors, crucial for determining their signaling fate. Understanding which proteins they interact with during these transitions is key to unlocking how they control cell behavior.
But traditional techniques can’t track protein interactions in real-time as receptors move through different parts of the cell. That’s where APEX2 comes into play.
How the Study Worked
Researchers genetically fused APEX2, a specialized enzyme, to the tail of the LHR. This enzyme acts like a molecular “spray can,” tagging nearby proteins with biotin in the presence of biotin-phenol and hydrogen peroxide. This allows scientists to capture a precise snapshot of LHR’s surroundings—down to a 20-nanometer radius—at specific moments in time.
Here’s how they did it:
Cells expressing LHR-APEX2 were prepped and treated with Golden West’s luteinizing hormone
The team applied LH at different timepoints (1, 2, 3, 5, and 10 minutes) to mimic real-world receptor activation and internalization dynamics.
At each timepoint, they initiated the APEX2 labeling reaction and stopped it quickly to “freeze” the interaction landscape.
Biotin-tagged proteins were pulled down and identified via high-resolution mass spectrometry.
Thanks to the consistency and potency of the LH reagent, the team was able to create a clear, time-resolved map of the receptor's interactome.
What Researchers Found
Out of thousands of proteins identified, two stood out: RAP2B and RAB38. These proteins had opposing roles:
RAP2B helped boost LHR signaling and directed it toward the VEE.
RAB38, in contrast, seemed to suppress signaling and promote a different trafficking route.
When RAP2B was silenced, the LHR got rerouted to early endosomes, cutting off its normal signal output. RAB38 knockdown, however, enhanced receptor signaling—suggesting it acts as a brake under normal conditions.
LH Hormone
The use of the LH Hormone was critical to the study’s success. Its high purity and activity ensured reproducible receptor activation, which is especially important when measuring fast, transient interactions like those in GPCR signaling. Without a consistent trigger, the fine-tuned temporal resolution of this study would not have been possible.
The Bigger Picture
This research doesn’t just deepen our understanding of LHR—it offers a blueprint for studying other GPCRs that move through the cell or have few known tools. With this approach, scientists can now investigate receptor behavior in hard-to-reach places and discover new regulators of cell signaling.
As our understanding of GPCR signaling becomes more refined, so too will our ability to target these receptors in disease—from fertility disorders to hormone-responsive cancers.
References
Shchepinova, M. M., Richardson, R., Houghton, J. W., Walker, A. R., Safar, M. A., Conole, D., Hanyaloglu, A. C., & Tate, E. W. (2025). "Spatiotemporally resolved GPCR interactome uncovers unique mediators of receptor agonism." Cell Chemical Biology. DOI: 10.1016/j.chembiol.2025.04.006.
View Original Research Paper's PDF
View PDF